Mesoblast Ltd (MESO) stock

MESONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30Also trades as MEOBF

Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Aug 27, 2026Score 6/30

$13.27+0.17 (+1.30%)

Close on Nov 13, 2026Market cap $1.72BP/E –Yield –

Mesoblast statistics

75 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: –
Last ex-dividend date: No dividends
Fundamentals through: Jun 30, 2026
Share price as of: Nov 13, 2026

Valuation ratiosIndustry

Market Cap: $1.72B; $272.32M
Enterprise Value: $1.75B; $146.23M
PS Ratio: 14.31; 3.66

Enterprise valuationIndustry

EV / Sales: 14.54; 2.57

Share statisticsIndustry

Shares Outstanding: 1.30B; 58M
Shares Change (YoY): 7.21%; 10.8%
Float: 814M; 49M
Shares Held by Insiders: 37.3%; 11.7%
Shares Held by Institutions: 0.30%; 56.4%

Short sellingIndustry

Short Interest: 4M; –
Short Interest Change: 9.49%; -0.80%
Days to Cover: 10.16; 5.15

Stock price statisticsIndustry

52-Week High: $21.50; –
52-Week Low: $11.89; –
20-Day Moving Average: $13.61; –
50-Day Moving Average: $14.32; –
200-Day Moving Average: $15.21; –
Average True Range (14): $0.64; –
Price Change (1 Week): -7.01%; -1.15%
Price Change (1 Month): -4.87%; -4.87%
Price Change (3 Months): -22.0%; -21.0%
Price Change (6 Months): -11.5%; -20.6%
Price Change (YTD): -26.4%; -23.6%
Price Change (1 Year): -15.5%; -22.4%
Price Change (3 Years): 443.9%; -29.5%
Price Change (5 Years): 5.82%; -77.9%
Price Change (10 Years): 32.4%; -65.4%
Average Volume (10 Days): 227,659; –
Average Volume (20 Days): 280,338; –
Average Volume (90 Days): 246,996; –
Relative Volume: 1.41; 0.70
Relative Strength Index (14): 43.9; 43.4
Volatility (1 Year): 57.3%; 80.1%
Beta (5 Years): 1.50; 1.07

MarginsIndustry

Gross Margin: 86.1%; 53.1%
Pretax Margin: -47.3%; -11.6%
Profit Margin: -47.8%; -31.6%
EBITDA Margin: -20.3%; -27.7%
FCF Margin: -37.1%; -9.56%

Returns on capitalIndustry

Return on Assets (ROA): -7.38%; -40.6%

Financial positionIndustry

Current Ratio: 2.43; 3.30
Quick Ratio: 1.98; 2.39

GrowthIndustry

Revenue Growth (YoY): 599.2%; 6.82%
Revenue Growth (3Y CAGR): 152.1%; 2.25%
Revenue Growth (5Y CAGR): 74.5%; 6.41%

EfficiencyIndustry

Asset Turnover: 0.15; 0.40
Inventory Turnover: 0.66; 2.73
Revenue Per Employee: $1.11M; $429.29K
Profits Per Employee: -$532.41K; -$689.41K
Employee Count: 108; 74
WACC: 12.5%; 10.2%

Income statement (TTM)Industry

Revenue: $120.25M; $66.37M
Gross Profit: $103.58M; $120.78M
Pretax Income: -$56.89M; -$12.95M
Net Income: -$57.50M; -$22.35M
EBITDA: -$24.46M; -$17.21M
EPS (Diluted): -$0.04; -$0.76

Balance sheetIndustry

Cash & Short-Term Investments: $102.91M; $68.68M
Total Debt: $129.83M; $116.91M
Net Cash (Debt): -$26.92M; $17.76M
Net Cash Per Share: -$0.02; $0.80
Working Capital: $116.38M; $79.99M

Cash flow (TTM)Industry

Operating Cash Flow: -$43.83M; -$12.38M
Capital Expenditures: -$833.00K; -$1.00M
Free Cash Flow: -$44.66M; -$18.21M
FCF Per Share: -$0.03; -$0.42

Dividends and yieldsIndustry

Earnings Yield: -3.34%; -21.8%
FCF Yield: -2.60%; -9.44%
Buyback Yield: -0.15%; -0.76%
Shareholder Yield: -0.15%; 0.00%

Taxes and interestIndustry

Interest Expense: $23.84M; $2.90M
Income Tax: $613.00K; $73.00K

Scores and fair valueIndustry

Altman Z-Score: 3.45; 0.23
Piotroski F-Score: 5; 4
Beneish M-Score: 2.37; -2.63

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

Period	MESO	S&P 500	Difference	MESO per year	S&P 500 per year
1 month	-4.5%	-3.0%	−1.5 pts
3 months	-19.5%	-2.8%	−16.7 pts
Year to date	-26.4%	+11.5%	−37.9 pts
1 year	-11.1%	+13.5%	−24.5 pts
3 years	+418.4%	+77.7%	+340.7 pts	+73.1%	+21.1%
5 years	+5.8%	+72.6%	−66.8 pts	+1.1%	+11.5%
10 years	+42.7%	+308.2%	−265.5 pts	+3.6%	+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

4M MESO shares were sold short on Oct 30, 2026, up 9.5% from the previous report. At recent volumes it would take 10.2 days to buy them back. Over the last 20 sessions, 44.6% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	3,577,405	+9.5%	351,993	10.2
Oct 15, 2026	3,267,459	-1.1%	248,501	13.2
Sep 30, 2026	3,304,378	-0.2%	215,062	15.4
Sep 15, 2026	3,309,661	+4.7%	170,756	19.4
Aug 31, 2026	3,160,697	+4.9%	234,300	13.5
Aug 14, 2026	3,012,363	-5.1%	164,995	18.3
Jul 31, 2026	3,174,715	+1.3%	286,984	11.1
Jul 15, 2026	3,132,487	+0.9%	284,245	11.0
Jun 30, 2026	3,103,325	-0.2%	209,001	14.8
Jun 15, 2026	3,108,248	+1.5%	147,876	21.0
May 29, 2026	3,061,116	+4.1%	177,675	17.2
May 15, 2026	2,941,703	+1.2%	164,276	17.9